Speaker events at the Congress in Washington, DC, last week included discussion on two current pressing issues.
The first examined issues around pharma companies choosing speakers for their sponsored events. There are strict guidelines that need to be followed under regulatory agencies such as HHS-OIG.
“There has to be a
Free Trial
Register for free to keep reading.
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day
